Aurum Wealth Management Group »

Bridgebio Pharma shares owned by Aurum Wealth Management Group

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Aurum Wealth Management Group from 13F filings

Historical chart of Aurum Wealth Management Group investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Aurum Wealth Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Aurum Wealth Management Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.5k 10k 0.85
2023-09-30 $7.5k 10k 0.75

More positions owned by Aurum Wealth Management Group

Ishares Tr Core S&p500 Etf (IVV)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core S&p Scp Etf (IJR)
Vaneck Etf Trust Cef Muni Income (XMPT)
Apple (AAPL)
United Parcel Service CL B (UPS)
Microsoft Corporation (MSFT)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Aurum Wealth Management Group

Top funds holding Bridgebio Pharma

Braidwell
Ubs Global Asset Management Americas
D. E. Shaw & Co
Weiss Asset Management LP[1
Aristeia Capital
Context Capital Management
Laurion Capital Management
Point72 Asset Management
DeepCurrents Investment Group
Diameter Capital Partners
Wells Fargo & Company
Aequim Alternative Investments
Segantii Capital Management
Calamos Advisors
Lord, Abbett & Co

View all funds holding Bridgebio Pharma